EUVIMEDEUVIMED entdecken
EditorialKommentarLeitlinie

Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward

Yoon K Loke

Drug Safety · 2024

DOI: 10.1007/s40264-024-01441-5 ↗

Kurz gefasst

Editorial in der Zeitschrift Drug Safety, 2024. Verfasst von Yoon K Loke. Beteiligte Einrichtung: Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. y.loke@uea.ac.uk. Hauptthemen laut MEDLINE: Guidelines as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guidelines as TopicHumansAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsPeriodicals as Topic

Autor:innen und Institutionen

  • Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. y.loke@uea.ac.uk.

Zitieren

APA

Loke, Y. K. (2024). Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward. Drug Safety. https://doi.org/10.1007/s40264-024-01441-5

Vancouver

Loke YK. Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward. Drug Safety. 2024. doi:10.1007/s40264-024-01441-5

BibTeX
@article{Loke2024,
  author = {Loke, Yoon K},
  title = {Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward},
  journal = {Drug Safety},
  year = {2024},
  doi = {10.1007/s40264-024-01441-5}
}
Kostenlos starten →